These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 11358414)

  • 1. How do you diagnose rheumatoid arthritis early?
    Quinn MA; Green MJ; Conaghan P; Emery P
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):49-66. PubMed ID: 11358414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
    González-Gay MA; Hajeer AH; García-Porrúa C; Dababneh A; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2002 Feb; 29(2):271-5. PubMed ID: 11842822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of early rheumatoid arthritis.
    Brown AN
    J S C Med Assoc; 2003 Oct; 99(10):296-302. PubMed ID: 14621660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of rheumatoid arthritis.
    Rindfleisch JA; Muller D
    Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with newly diagnosed rheumatoid arthritis.
    Emery P; Marzo H; Proudman S
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():27-31. PubMed ID: 10646487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early referral and treatment of patients with acute arthritis. Experiences from two early arthritis clinics].
    Lindegaard HM; Hørslev-Petersen K; Junker P
    Ugeskr Laeger; 2005 Nov; 167(47):4458-61. PubMed ID: 16305765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for altering rheumatoid arthritis outcome.
    Quinn MA; Emery P
    Rheum Dis Clin North Am; 2005 Nov; 31(4):763-72. PubMed ID: 16287596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early rheumatoid arthritis.
    Mitchell KL; Pisetsky DS
    Curr Opin Rheumatol; 2007 May; 19(3):278-83. PubMed ID: 17414956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence supporting the benefit of early intervention in rheumatoid arthritis.
    Emery P
    J Rheumatol Suppl; 2002 Nov; 66():3-8. PubMed ID: 12435162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years.
    Flatø B; Lien G; Smerdel A; Vinje O; Dale K; Johnston V; Sørskaar D; Moum T; Ploski R; Førre Ø
    J Rheumatol; 2003 Feb; 30(2):386-93. PubMed ID: 12563700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
    Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P
    Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.
    Nyhäll-Wåhlin BM; Petersson IF; Nilsson JA; Jacobsson LT; Turesson C;
    Rheumatology (Oxford); 2009 Apr; 48(4):416-20. PubMed ID: 19213849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new study.
    Kary S; Fritz J; Scherer HU; Burmester GR
    Rheumatology (Oxford); 2004 Jul; 43(7):819-20. PubMed ID: 15187247
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial management of rheumatoid arthritis.
    Gramling A; O'Dell JR
    Rheum Dis Clin North Am; 2012 May; 38(2):311-25. PubMed ID: 22819086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?
    March L; Lapsley H
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):171-85. PubMed ID: 11358421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.